ArticleExperimental & molecular medicine2025

Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones.

Namhee Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.